New therapeutic agents for cancer are initially investigated in patients by means of Phase I clinical trials designed to evaluate the pharmacology, toxicities, and biological effects of the agents.

• 这次实验的目的有三个：1。在难治性实体肿瘤病人身上检测康莱特抗癌注射液最大耐受剂量和安全性（指毒副作用）。